Nonetheless, emerging clinical trials have evidently indicated that substantial improvements in disease suppression via the inhibition of VEGF/VEGFR and PDGF/PDGFR signals for destabilizing tumor vasculature and simultaneously inducing cell cycle arrest and apoptosis [28] remain difficult to achieve [29]. The gene discussed is PDGFRB; the disease is neoplasm.